Product NDC: | 61703-360 |
Proprietary Name: | Carboplatin |
Non Proprietary Name: | CARBOPLATIN |
Active Ingredient(s): | 10 mg/mL & nbsp; CARBOPLATIN |
Administration Route(s): | INTRAVENOUS |
Dosage Form(s): | INJECTION, SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 61703-360 |
Labeler Name: | Hospira Worldwide, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA076517 |
Marketing Category: | ANDA |
Start Marketing Date: | 20091217 |
Package NDC: | 61703-360-22 |
Package Description: | 1 VIAL in 1 CARTON (61703-360-22) > 15 mL in 1 VIAL |
NDC Code | 61703-360-22 |
Proprietary Name | Carboplatin |
Package Description | 1 VIAL in 1 CARTON (61703-360-22) > 15 mL in 1 VIAL |
Product NDC | 61703-360 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | CARBOPLATIN |
Dosage Form Name | INJECTION, SOLUTION |
Route Name | INTRAVENOUS |
Start Marketing Date | 20091217 |
Marketing Category Name | ANDA |
Labeler Name | Hospira Worldwide, Inc. |
Substance Name | CARBOPLATIN |
Strength Number | 10 |
Strength Unit | mg/mL |
Pharmaceutical Classes | Platinum-based Drug [EPC],Platinum-containing Compounds [Chemical/Ingredient] |